Business · 08/01/2010
FDA Releases Draft Guidance on Planning for High Absenteeism in Drug Production
The FDA has released a draft guidance to help manufacturers prepare for emergencies that may lead to high absenteeism at production facilities, ensuring the availability of medically necessary drug products.
Original source language: Federal Register — Health and Human ServicesOpen original release →